2021 HAN Messages
- 0461 – 12/31/2021
Using Therapeutics to Prevent and Treat COVID-19 - 0460 – 12/24/2021
Rapid Increase of Omicron Variant Infections in the United States: Management of Healthcare Personnel with SARS-CoV-2 Infection or Exposure - 0459 – 12/01/2021
New SARS-CoV-2 Variant of Concern Identified: Omicron (B.1.1.529) Variant - 0458 – 11/24/2021
Increasing Seasonal Influenza A (H3N2) Activity, Especially Among Young Adults and in College and University Settings, During SARS-CoV-2 Co-Circulation - 0457 – 11/04/2021
Update: Expansion of Recall of LeadCare Blood Lead Tests Due to Risk of Falsely Low Results - 0456 – 11/03/2021
Source Identified and Case Definition Established: Multistate Investigation of Non-travel Associated Burkholderia pseudomallei Infections (Melioidosis) in Four Patients: Georgia, Kansas, Minnesota, and Texas – 2021 - 0455 – 10/22/2021
Source Implicated in Fatal Case in Georgia: Multistate Outbreak of Non-travel Associated Burkholderia pseudomallei Infections (Melioidosis) in Four Patients: Georgia, Kansas, Minnesota, and Texas–2021 - 0454 – 10/14/2021
Expansion of Recall of LeadCare Blood Lead Tests Due to Risk of Falsely Low Results - 0453 – 09/29/2021
COVID-19 Vaccination for Pregnant People to Prevent Serious Illness, Deaths, and Adverse Pregnancy Outcomes from COVID-19 - 0452 – 09/20/2021
Guidance for Clinicians Caring for Individuals Recently Evacuated from Afghanistan - 0451 – 09/14/2021
Increases in Availability of Cannabis Products Containing Delta-8 THC and Reported Cases of Adverse Events - 0450 – 08/28/2021
Hurricane Ida—Clinical Guidance for Carbon Monoxide (CO) Poisoning - 0449 – 08/26/2021
Rapid Increase in Ivermectin Prescriptions and Reports of Severe Illness Associated with Use of Products Containing Ivermectin to Prevent or Treat COVID-19 - 0448 – 08/9/2021
New Case Identified: Multistate Investigation of Non-travel Associated Burkholderia pseudomallei Infections (Melioidosis) in Four Patients: Georgia, Kansas, Minnesota, and Texas—2021 - 0447 – 07/27/2021
Vaccination to Prevent COVID-19 Outbreaks with Current and Emergent Variants — United States, 2021 - 0446 – 07/17/2021
Potential Exposure to Person with Confirmed Human Monkeypox Infection — United States, 2021 - 0445 – 07/06/2021
Recall of LeadCare® Blood Lead Tests Due to Risk of Falsely Low Results - 0444 – 06/30/2021
Multistate Investigation of Non-travel Associated Burkholderia pseudomallei Infections (Melioidosis) in Three Patients: Kansas, Texas, and Minnesota—2021 - 0443 – 06/10/2021
Increased Interseasonal Respiratory Syncytial Virus (RSV) Activity in Parts of the Southern United States - 0442 – 04/13/2021
Cases of Cerebral Venous Sinus Thrombosis with Thrombocytopenia after Receipt of the Johnson & Johnson COVID-19 Vaccine - 0441 – 03/31/2021
Acute Non-Viral Hepatitis of Unknown Etiology Potentially Associated with an Alkaline Water Product - 0440 – 02/17/2021
2021 Winter Storms—Clinical Guidance for Carbon Monoxide (CO) Poisoning - 0439 – 02/12/2021
Extensively Drug-Resistant Salmonella Typhi Infections Among U.S. Residents Without International Travel
Additional Resources
Page last reviewed: March 28, 2019
Content source: Center for Preparedness and Response (CPR)